Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An unusual karyotype in preleukemia

J L Watt, R R Khaund, S G Allan

    Cancer Genetics and Cytogenetics
    |September 1, 1982
    PubMed
    Summary

    This study details a rare preleukemia case with a unique, complex abnormal karyotype in all bone marrow cells. The findings explore the significance of these chromosomal abnormalities in myeloproliferative disorders.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Evaluation of the NuCLEUS-X™ balloon valvuloplasty catheter for severe pulmonic stenosis in dogs.

    Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2020
    Same author

    Using RNA Sequencing to Characterize the Tumor Microenvironment.

    Methods in molecular biology (Clifton, N.J.)·2019
    Same author

    The NSW brain tissue resource centre: Banking for alcohol and major neuropsychiatric disorders research.

    Alcohol (Fayetteville, N.Y.)·2016
    Same author

    Quizartinib elicits differential responses that correlate with karyotype and genotype of the leukemic clone.

    Leukemia·2015
    Same author

    Novel TKI-resistant BCR-ABL1 gatekeeper residue mutations retain in vitro sensitivity to axitinib.

    Leukemia·2015
    Same author

    Integrative review on the non-invasive management of lower urinary tract symptoms in men following treatments for pelvic malignancies.

    International journal of clinical practice·2015

    Area of Science:

    • Hematology
    • Cytogenetics
    • Oncology

    Background:

    • Myeloproliferative disorders (MPDs) are a group of clonal bone marrow stem cell diseases.
    • Preleukemia, or the myelodysplastic syndrome (MDS), represents a precursor state to acute myeloid leukemia (AML).
    • Nonrandom chromosomal abnormalities are frequently observed in MPDs and AML, often correlating with prognosis.

    Observation:

    • A single, highly complex, and abnormal karyotype was identified in 100% of bone marrow cells in a patient with a myeloproliferative disorder classified as preleukemia.
    • The karyotype exhibited multiple deletions (chromosomes -2, -5, -7, -8, -11, -12, -13, -14), translocations (t(2;5), t(11;12), t(16;17)), an extra chromosome (+17), and three or four dicentric markers.
    • This specific combination of chromosomal aberrations is unusual and potentially unique.

    Findings:

    • The observed karyotype (45, XY, -2, -5, -7, -8, -11, -12, -13, -14, + t(2;5), +t(11;12), +t(16;17), +17, plus three or four dicentric markers) represents a significant deviation from known nonrandom chromosomal patterns in hematologic malignancies.
    • Correlation of these unique chromosomal changes with the patient's hematologic and clinical status provides insights into their potential role in disease progression.
    • The presence of such a complex karyotype in 100% of cells suggests a critical genetic event driving the myeloproliferative disorder.

    Implications:

    • Understanding the significance of this unique karyotype may refine diagnostic and prognostic criteria for preleukemia and related myeloproliferative disorders.
    • This case highlights the heterogeneity of genetic alterations in hematologic malignancies and the importance of detailed cytogenetic analysis.
    • Further research into the functional impact of these specific chromosomal abnormalities could reveal novel therapeutic targets for preleukemia and acute nonlymphoblastic leukemias.

    Related Experiment Videos